Bridgetech Partners With Amcare Labs
SOLANA BEACH, Calif., May 26 /PRNewswire-FirstCall/ -- Bridgetech Holdings International, Inc. , a company focused on maximizing the potential of emerging healthcare products and services in the U.S. and Asian markets, today announced the establishment of a joint venture with Amcare Labs International, Inc. (Amcare), an affiliate of Johns Hopkins Medicine International, to form Medical Testing Facilities (LAB) within China, Hong Kong and Taiwan.
The LAB, jointly owned by Bridgetech and Amcare, will bring state of the art clinical diagnostic services to China. It will also provide a full spectrum of laboratory services including anatomic pathology, cytology, molecular diagnostics, high end immunology, cytogenetics, and flowcytometry to the physicians and patients in China. In addition, the LAB, will provide second opinion services from Johns Hopkins Medical Laboratories in Baltimore, USA.
"This is another significant milestone toward achieving our long-term goal of becoming a leading developer of commercialized healthcare products and services in China," said Herbert Wong, Chairman of Bridgetech Holdings International, Inc. "By establishing the LAB with Amcare, an affiliate of the world renowned Johns Hopkins Medicine, we add the pathology analysis market in along with the CRO market.
"We believe that our relationships and resources in China, coupled with Amcare's reputation within the international medical community, will allow us achieve our goal," continued Mr. Wong. "In addition, the success of this joint venture will also position us very well to achieve other key components of our business strategy including leveraging our resources to successfully commercialize additional promising healthcare services and products in Asia.
"We are very pleased to enter this strategic relationship with Bridgetech. We believe the LAB is another key milestone, and helps us towards becoming the leading provider of reference laboratory services in markets outside of the U.S.," said Dr. Mohan Chellappa, President of Amcare.
About Amcare Labs International, Inc.
Amcare is a Delaware corporation and an affiliate of the Johns Hopkins Medicine International organization. It was founded in July of 2001 with the objective of becoming the leader in the non-U.S. markets for pathology and laboratory medicine services -- the medical testing facility business ("MTF"). Amcare provides specialized testing, laboratory medical education, and other related medical services derived from the skill, technology, expertise, standards, services and resources owned by or associated with Johns Hopkins Medical Institutions.
About Bridgetech Holdings International, Inc.
Bridgetech is leveraging its extensive network of relationships in China and the U.S. to capitalize on proprietary opportunities in high growth segments of the healthcare industry. Bridgetech is expanding its U.S. operations by adding products and services that have the highest probability for incremental success in China. In addition to the China healthcare market, Bridgetech is focusing on the areas of medical imaging and non-invasive surgery, nurse recruitment and training, and hospital asset management.
Statements contained in this press release that are not statements of historical fact are "forward-looking statements" as that term is defined under federal securities laws, including, without limitation, all statements concerning expectations, beliefs, goals, intentions or strategies for the future of Bridgetech and Amcare. Forward-looking statements may be identified by words such as "goals," "plans," "believes," "will," "expects" and other words of similar meaning used in conjunction with, among other things, discussions of future operations, financial performance, product development and new ventures. Many factors could cause actual events or results to differ materially from those expressed in any forward-looking statement. Investors are cautioned not to place undue reliance on any forward-looking statements.
Investor Relations: Redwood Consultants, LLC 415-884-0348 Media: EVC Group, Inc. Steve DiMattia 917-620-0590 Approved by: Bridgetech Holdings International, Inc. Thomas C. Kuhn III 678-428-3507Bridgetech Holdings International, Inc.
CONTACT: Investor Relations, Redwood Consultants, LLC, +1-415-884-0348;or Media, Steve DiMattia of EVC Group, Inc., +1-917-620-0590, both forBridgetech Holdings International, Inc.; or Thomas C. Kuhn III of BridgetechHoldings International, Inc., +1-678-428-3507